# Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.

> **NCT07466420** · NA · RECRUITING · sponsor: **Katerina M. Antoniou** · enrollment: 100 (estimated)

## Conditions studied

- Fibrotic Interstitial Lungs Diseases
- Idiopathic Pulmonary Fibrosis (IPF)
- Progressive Pulmonary Fibrosis

## Interventions

- **DIETARY_SUPPLEMENT:** Quercetin (dietary supplement)
- **DRUG:** Usual treatment

## Key facts

- **NCT ID:** NCT07466420
- **Lead sponsor:** Katerina M. Antoniou
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-26
- **Primary completion:** 2028-01-31
- **Final completion:** 2029-01-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07466420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07466420, "Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07466420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*